Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $14,262 - $19,458
-1,035 Reduced 2.55%
39,475 $742,000
Q4 2023

Feb 13, 2024

SELL
$10.95 - $17.32 $190,584 - $301,454
-17,405 Reduced 30.05%
40,510 $584,000
Q3 2023

Nov 14, 2023

BUY
$16.59 - $23.77 $721,150 - $1.03 Million
43,469 Added 300.91%
57,915 $1.01 Million
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $5,076 - $7,602
-237 Reduced 1.61%
14,446 $339,000
Q4 2022

Feb 14, 2023

SELL
$23.31 - $28.61 $71,608 - $87,889
-3,072 Reduced 17.3%
14,683 $410,000
Q3 2022

Nov 16, 2022

SELL
$23.4 - $34.25 $55,387 - $81,069
-2,367 Reduced 11.76%
17,755 $415,000
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $500,322 - $614,736
-15,803 Reduced 43.99%
20,122 $678,000
Q1 2022

May 16, 2022

SELL
$30.45 - $39.36 $906,892 - $1.17 Million
-29,783 Reduced 45.33%
35,925 $1.25 Million
Q4 2021

Feb 15, 2022

SELL
$28.67 - $37.13 $265,770 - $344,195
-9,270 Reduced 12.36%
65,708 $2 Million
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $75,611 - $94,125
-2,641 Reduced 3.4%
74,978 $2.46 Million
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $2.21 Million - $2.95 Million
77,619 New
77,619 $2.35 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.96B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Glenmede Trust CO Na Portfolio

Follow Glenmede Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Glenmede Trust CO Na with notifications on news.